AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 16th, 2021 • Candel Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJuly 16th, 2021 Company Industry JurisdictionThis AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective November 13, 2018 (the “Effective Date”), by and between Advantagene, Inc., a Delaware corporation (the “Company”) and Estuardo Aguilar-Cordova (the “Employee”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 16th, 2021 • Candel Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJuly 16th, 2021 Company Industry JurisdictionThis AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective November 13, 2018 (the “Effective Date”), by and between Advantagene, Inc., a Delaware corporation (the “Company”) and Laura Aguilar, M.D., Ph.D. (the “Employee”).
EX-10.16 19 d361077dex1016.htm EX-10.16 EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2020 • Pennsylvania
Contract Type FiledMay 5th, 2020 JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective as of March 7, 2018, by and between Verrica Pharmaceuticals Inc., a Delaware corporation (the “Company”) and Patrick Burnett, MD, PhD, FAAD (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 5th, 2019 • Dova Pharmaceuticals Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledMarch 5th, 2019 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective December 17, 2018 (the “Effective Date”), which shall be Employee’s commencement of employment, by and between Dova Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and David S. Zaccardelli (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 18th, 2019 • Avedro Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledJanuary 18th, 2019 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”), by and between Avedro, Inc. (the “Company”) and [NAME] (the “Employee”), is entered into effective [DATE] (the “Effective Date”).
FORM OF AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • January 18th, 2019 • Avedro Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledJanuary 18th, 2019 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”), by and between Avedro, Inc. (the “Company”) and [NAME] (the “Employee”), is effective as of the date the Company consummates an initial public offering (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 15th, 2018 • Avedro Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 15th, 2018 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”), by and between Avedro, Inc. (the “Company”) and [NAME] (the “Employee”), is entered into effective [DATE] (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 22nd, 2018 • Verrica Pharmaceuticals Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledMay 22nd, 2018 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective January 30, 2018 (the “Effective Date”), by and between Verrica Pharmaceuticals Inc., a Delaware corporation (the “Company”) and Linda S. Palczuk (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 22nd, 2018 • Verrica Pharmaceuticals Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledMay 22nd, 2018 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective as of March 7, 2018, by and between Verrica Pharmaceuticals Inc., a Delaware corporation (the “Company”) and Patrick Burnett, MD, PhD, FAAD (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 22nd, 2018 • Verrica Pharmaceuticals Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledMay 22nd, 2018 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective January 6th, 2018 (the “Effective Date”), by and between Verrica Pharmaceuticals Inc., a Delaware corporation (the “Company”) and Joseph Bonaccorso (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2018 • Verrica Pharmaceuticals Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledMarch 30th, 2018 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective December 11, 2017 (the “Effective Date”), by and between Verrica Pharmaceuticals Inc., a Delaware corporation (the “Company”) and Ted White (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2018 • Verrica Pharmaceuticals Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledMarch 30th, 2018 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective February 7, 2018 (the “Effective Date”), by and between Verrica Pharmaceuticals Inc., a Delaware corporation (the “Company”) and Chris Degnan (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 2nd, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledJune 2nd, 2017 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective March 23, 2017 (the “Effective Date”), by and between Dova Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Kevin Laliberte (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 2nd, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledJune 2nd, 2017 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective April 14, 2017 (the “Effective Date”), by and between Dova Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Lee F. Allen, M.D., PH.D. (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 2nd, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledJune 2nd, 2017 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective March 1, 2017 (the “Effective Date”), by and between Dova Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Doug Blankenship (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 2nd, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledJune 2nd, 2017 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective January 3, 2017 (the “Effective Date”), by and between Dova Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Alexander C. Sapir (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • April 21st, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledApril 21st, 2017 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective April 14, 2017 (the “Effective Date”), by and between Dova Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Lee F. Allen, M.D., PH.D. (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • April 21st, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledApril 21st, 2017 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective January 3, 2017 (the “Effective Date”), by and between Dova Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Alexander C. Sapir (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • April 21st, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledApril 21st, 2017 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective March 1, 2017 (the “Effective Date”), by and between Dova Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Doug Blankenship (the “Employee”).